Challenging policy inertia for HF diagnosis: The Belgian Charter for Heart Failure
5 September, 2018
Natriuretic peptide (NP) testing is not always reimbursed in Belgium, despite being recommended in European guidelines as an important element of heart failure diagnosis. The Belgian Charter for Heart Failure demands reimbursement for guideline-recommended diagnostic tests as one of the five priorities for policy action. The initiative has been led by leading cardiac organisations and has been signed by 12,000 people to date.